Cargando…
2021–2022 Drug Updates: Investigational Therapeutics in the Pipeline
During JADPRO Live 2022, Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP, discussed investigational therapeutic agents in the drug development pipeline. Dr. Moore highlighted agents that represent either a new drug class, a novel mechanism of action, a rethinking of how to approach treating a diseas...
Autor principal: | Moore, Donald C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184839/ https://www.ncbi.nlm.nih.gov/pubmed/37197720 http://dx.doi.org/10.6004/jadpro.2023.14.3.11 |
Ejemplares similares
-
2020–2021 Drug Updates: Investigational Therapeutics in the Pipeline
por: Moore, Donald C.
Publicado: (2022) -
2021–2022 Drug Updates in Solid Tumors
por: Hanna, Kirollos
Publicado: (2023) -
2021–2022 Drug Updates in Hematologic Malignancies
por: Tobin, Jenni
Publicado: (2023) -
2020–2021 Drug Updates in Hematologic Malignancies
por: Hanna, Kirollos
Publicado: (2022) -
2020–2021 Drug Updates in Solid Tumors
por: Cambareri, Christine
Publicado: (2022)